The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2024

Filed:

May. 29, 2019
Applicants:

Neovacs, Paris, FR;

Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;

Institut Pasteur, Paris, FR;

Inventors:

Géraldine Grouard-Vogel, Paris, FR;

Eva Conde García, Paris, FR;

Romain Bertrand, Paris, FR;

Noémie Caillot, Paris, FR;

Laurent Reber, Antony, FR;

Pierre Bruhns, Paris, FR;

Vincent Serra, Bondoufle, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 17/00 (2006.01); A61K 39/00 (2006.01); A61K 47/54 (2017.01); A61K 47/64 (2017.01); A61P 11/00 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0008 (2013.01); A61K 47/545 (2017.08); A61K 47/646 (2017.08); A61P 11/00 (2018.01); A61P 17/00 (2018.01); A61P 37/06 (2018.01); A61P 37/08 (2018.01); A61K 2039/6037 (2013.01);
Abstract

An immunogenic product including a cytokine conjugated with a carrier protein, wherein the cytokine is selected from the group including IL-4, IL-13 and mixtures thereof, and wherein the carrier protein is CRM. Further, a method for manufacturing the immunogenic product. Also, the therapeutic use of the immunogenic product for treating an inflammatory disorder associated with aberrant IL-4 and/or IL-13 expression or activity.


Find Patent Forward Citations

Loading…